The Boston company, Pure Tech Ventures, express interest for licensing and partnership for R&D collaboration in the field of medical imaging.
News
Pure Tech Ventures in Boston express interest for innovative new imaging application with IC2
Welcome to ImmunoSigns
ImmunoSigns is a Biotech company founded in 1996. We offer you help in project management and R&D activities within biotechnology and immunodetection.
The core competance of ImmunoSigns is development and production of polyclonal and monoclonal antibodies and design and production of novel immunoassays and diagnostic kits, especially within the clinical area of diabetes and obesity.
© 2021 ImmunoSigns. All Rights Reserved.
Powered by WordPress. Designed by 